ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1167

Incidence of Primary Chronic Cutaneous Lupus Erythematosus in a Metropolitan Area of the Southeastern United States: The Georgia Lupus Registry

Cristina Drenkard1, Sareeta Parker2, Caroline Gordon3, Charles Hemlick4, Laura Aspey5, Gaobin Bao6 and S. Sam Lim6, 1Department of Medicine, Emory University School of Medicine, Atlanta, GA, 2Dermatology, Kaiser Permanente, Atlanta, GA, 3NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom, 4Centers for Disease Control and Prevention, Atlanta, GA, 5Dermatology, Emory University School of Medicine, Atlanta, GA, 6Medicine, Emory University School of Medicine, Atlanta, GA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: cutaneous lupus erythematosus and population studies

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Epidemiology and Public Health - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Chronic cutaneous lupus erythematosus CCLE is a group of immune mediated inflammatory disorders of the skin that often induce permanent disfigurement, leading to a substantial negative impact on patientsÕ quality of life. CCLE comprises discoid lupus erythematosus (DLE), lupus erythematosus profundus or lupus panniculitis (LEP), lupus erythematous tumidus (LET) and chilblain lupus erythematosus (CHLE). Relative to SLE, epidemiologic studies on CCLE are rare and limited to populations without racial diversity. This study provides minimum estimates of the incidence of DLE in particular, and CCLE in general, in a predominantly white and black population in the Southeastern United States.  

Methods: The Georgia Lupus Registry is a Centers for Disease Control and Prevention-funded registry conducted to estimate the burden of lupus in a large diverse population of the Southeastern United States. Multiple sources, including dermatology and rheumatology practices, multispecialty healthcare facilities, and dermatopathology reports were used to ascertain potential new cases of CCLE from 2002 through 2004. Cases with a clinical or clinical-histological diagnosis of DLE were classified as definite DLE. Cases ascertained exclusively from dermatopathology reports were categorized as probable DLE. Age-standardized rates were determined and stratified by race and sex for DLE in particular and CCLE in general.  

Results: The overall age-adjusted incidence of definite and combined (definite and probable) DLE were 2.9 and 3.7/100,000 person-years, respectively. Overall age-adjusted estimate for combined CCLE was 3.9/100,000 person-years. Black-to-white and female-to-male incidence ratios were 5.4 and 3.1 for definite DLE.

 

Conclusion: Our findings underscore striking racial disparities in the susceptibility for CCLE, with black people experiencing between three and five-fold increased incidence of CCLE in general and DLE in particular, compared to white people. Gender differences were consistent with those reported previously, with a 3 times higher risk of DLE in females compared to males.  


Disclosure: C. Drenkard, None; S. Parker, None; C. Gordon, None; C. Hemlick, None; L. Aspey, None; G. Bao, None; S. S. Lim, None.

To cite this abstract in AMA style:

Drenkard C, Parker S, Gordon C, Hemlick C, Aspey L, Bao G, Lim SS. Incidence of Primary Chronic Cutaneous Lupus Erythematosus in a Metropolitan Area of the Southeastern United States: The Georgia Lupus Registry [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/incidence-of-primary-chronic-cutaneous-lupus-erythematosus-in-a-metropolitan-area-of-the-southeastern-united-states-the-georgia-lupus-registry/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incidence-of-primary-chronic-cutaneous-lupus-erythematosus-in-a-metropolitan-area-of-the-southeastern-united-states-the-georgia-lupus-registry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology